OBINUTUZUMAB CAN BE ADMINISTERED AS A 90‐MINUTE SHORT‐DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: GAZELLE END OF INDUCTION ANALYSIS

Autor:	Takayuki Ishikawa, Miguel Canales, Thomas A. Buchholz, S. Pokala, E. Vorozheikina, Koji Izutsu, Laura Fogliatto, K. Hübel, Joana Parreira, Dirk Klingbiel, Monique S Tomiczek
Rok vydání:	2021
Předmět:	Cancer Research medicine.medical_specialty business.industry Follicular lymphoma Hematology General Medicine medicine.disease Gastroenterology chemistry.chemical_compound Oncology chemistry Obinutuzumab Internal medicine medicine End of induction In patient business Short duration
Zdroj:	Hematological Oncology. 39
ISSN:	1099-1069 0278-0232
DOI:	10.1002/hon.30_2880
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ae3842f5a054e75aee096f6ad188412f https://doi.org/10.1002/hon.30_2880 Zobrazit plný text záznamu Plný text